Author | Kelly Dowhower Karpa, PhD, RPh


New drug approved for treating hypertension

April 02, 2007

Aliskiren (Tekturna, Novartis) is a new molecular entity approved for treating hypertension either as monotherapy or in conjunction with other antihypertensive agents.

Combo antihypertensive gets FDA nod

February 05, 2007

Two commonly prescribed antihypertensive medications have now been combined into one tablet. With an anticipated availability this September, valsartan (Diovan, Novartis) and amlodipine (Norvasc, Pfizer) will be sold as a combination product under the trade name Exforge (Novartis). The Food & Drug Administration approval is tentative, pending expiration of market exclusivity and patent protection for amlodipine in September.

Experts urge caution over use of methadone

December 11, 2006

Recent news reports linking methadone with a number of casualties, including that of the actress Anna Nicole Smith's son, have fostered the idea that the substance is a "killer" or dangerous drug of abuse. This is a bit paradoxical since methadone has been successfully used in heroin detoxification programs for decades.

Attacking brain tumors head-on

September 18, 2006

In the past, pharmacists played a somewhat limited role in the care and treatment of brain cancer. But all that is changing.